Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs

Christina Charles-Schoeman; Gerd Burmester; Peter Nash; Cristiano A F Zerbini; Koshika Soma; Kenneth Kwok; Thijs Hendrikx; Eustratios Bananis; Roy Fleischmann

Annals of the Rheumatic Diseases (2016) - Comments
pubmed: 26275429 doi: 10.1136/annrheumdis-2014-207178 issn: 1468-2060 issn: 0003-4967

Christina Charles-Schoeman, Gerd Burmester, Peter Nash, Cristiano A F Zerbini, Koshika Soma, Kenneth Kwok, Thijs Hendrikx, Eustratios Bananis, Roy Fleischmann